Reassessing therapeutic antibodies for neglected and tropical diseases

• Rob Hooft van Huijsduijnen,

  Affiliation Medicines for Malaria Venture, Geneva, Switzerland

  ⨯
• Somei Kojima,

  Affiliation Chiba-Nishi General Hospital, Chiba, Japan

  ⨯
• Dee Carter,

  Affiliation School of Life and Environmental Sciences and The Marie Bashir Institute, University of Sydney, NSW, Australia

  http://orcid.org/0000-0002-4638-0059

  ⨯
• Hisafumi Okabe,

  Affiliation Chugai Pharmaceutical Co, Ltd., Tokyo, Japan

  ⨯
• Akihide Sato,

  Affiliation Chugai Pharmaceutical Co, Ltd., Tokyo, Japan

  ⨯
• Wataru Akahata,

  Affiliation VLP Therapeutics, Gaithersburg, Maryland, United States of America

  ⨯
• Timothy N. C. Wells,

  Affiliation Medicines for Malaria Venture, Geneva, Switzerland

  ⨯
• Kei Katsuno

  * E-mail: kei.katsuno@lshtm.ac.uk

  Affiliations Global Health Innovative Technology Fund, Tokyo, Japan, London School of Hygiene and Tropical Medicine, London, United Kingdom, Nagasaki University School of Tropical Medicine and Global Health, Nagasaki, Japan

  ⨯